Rate My Professor Tristan Clark

Clark has led multiple clinical trials evaluating diagnostics for COVID-19, influenza, respiratory syncytial virus, and other infections, establishing point-of-care testing services at University Hospital Southampton. During the COVID-19 pandemic, he advised the Department of Health and Social Care on testing strategies. He chairs the British Infection Association since 2016 and the NIHR Clinical Research Network Coordinating Centre since 2018. In 2025, he received the NIHR Research Professorship to address antimicrobial resistance through host response-based diagnostics. Awards include the University of Southampton Vice-Chancellor's Award for Research Impact (2022), University Hospital Southampton Hospital Superheroes Awards (2021, 2018), NIHR Post-Doctoral Fellowship (2016), and Fellowship of the Royal College of Physicians (2020). Key publications encompass 'Recent advances in the influenza virus vaccine landscape: a comprehensive overview of technologies and trials' (Clinical Microbiology Reviews, 2024), 'Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75–79 years in England' (The Lancet Infectious Diseases, 2025), and 'Understanding risk of poor outcomes in adults hospitalised with respiratory syncytial virus infection: evidence from a multicentre UK cohort' (Thorax, 2026). He has spoken at conferences on point-of-care testing and respiratory viruses and contributes to advisory boards for pharmaceutical companies.